학술논문
Risk-adapted bendamustine + rituximab is a tolerable treatment alternative for elderly patients with chronic lymphocytic leukaemia: a regional real-world report on 141 consecutive Swedish patients
Document Type
Artikel
Author
Source
British journal of haematology. 191(3):426-432
Subject
Language
English
English
English
ISSN
1365-2141